4 Basebio Ag Na O.N Előre P/E

Mi az 4 Basebio Ag Na O.N Előre P/E?

A Előre P/E az 4 Basebio Ag Na O.N. - N/A

Mi a Előre P/E meghatározása?



Az előrejelzett ár / jövedelem arány a vállalat tőzsdei árának és a társaság becsült részvényenkénti eredményének aránya a következő tizenkét hónapban.

The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.

Mit csinál 4 Basebio Ag Na O.N?

2invest AG, an investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally. The company was formerly known as 4basebio AG and changed its name to 2invest AG in January 2021. 2invest AG is based in Heidelberg, Germany.